Metabotropic Glutamate Receptors in Central Nervous System Diseases
Journal:
Current Drug Targets
Volume:
17
Page:
538-616
Author(s):
LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson’s Disease, Where Do We Stand?
Journal:
Current Neuropharmacology
Volume:
14
Page:
214-225
Author(s):
Jean-Marc Taymans and Elisa Greggio
The Unbiased Search of Biomarkers in Neurodegenerative Diseases
Journal:
Current Pharmaceutical Biotechnology
Volume:
17
Page:
471-479
Author(s):
Pascual Ferrara
Cognitive - Behavioral Therapy in Central Sensitivity Syndromes
Journal:
Current Rheumatology Reviews
Volume:
12
Page:
2-12
Author(s):
David A. Williams
Tardive Dyskinesia and Covert Dyskinesia with Aripiprazole: A Case Series
Journal:
Current Drug Safety
Volume:
11
Page:
102-103
Author(s):
Suravi Patra
Cognitive Behavioral Therapy for Psychosis Prevention and Treatment in Youth
Journal:
Current Psychiatry Reviews
Volume:
12
Page:
79-87
Author(s):
Elena I. Rasskazova and Robert D. Friedberg
Cognitive-Behavioral Therapy for Youth with Obsessive-Compulsive and Related Disorders
Journal:
Current Psychiatry Reviews
Volume:
12
Page:
37-52
Author(s):
Brittany M. Riggin and Caleb W. Lack
Protein Folding and Misfolding, Endoplasmic Reticulum Stress in Neurodegenerative Diseases: in Trace of Novel Drug Targets
Journal:
Current Protein & Peptide Science
Volume:
17
Page:
169-182
Author(s):
Botond Penke, Ferenc Bogár and Lívia Fülöp
Nigella sativa – A Functional Spice From A Pharaoh’s Tomb to Modern Healthcare
Journal:
The Natural Products Journal
Volume:
6
Page:
13-26
Author(s):
Anna Mrozek-Wilczkiewicz and Robert Musiol
Conventional and New Antiepileptic Drugs on Vitamin D and Bone Health: What We Know to Date?
Journal:
Current Clinical Pharmacology
Volume:
11
Page:
69-70
Author(s):
Antonio Siniscalchi, Giovambattista De Sarro, Andzelika Michniewicz and Luca Gallelli